Martin Augsten

Q: What is Martin Augsten email address?

Email Martin Augsten at augsten@gmx.net and martin.augsten@boehringer-ingelheim.com. This email is the most updated Martin Augsten's email found in 2026.

Q: How to contact Martin Augsten?

To contact Martin Augsten send an email to augsten@gmx.net or martin.augsten@boehringer-ingelheim.com. (updated on February 24, 2025)

Principal Scientist & Lab Head at Boehringer Ingelheim | Dossenheim, Baden-Württemberg, Germany

About Martin Augsten

Martin Augsten currently serves as Principal Scientist and Laboratory Head at Boehringer Ingelheim, where he leads cutting-edge research initiatives focused on understanding the complex molecular mechanisms underpinning tumor progression and malignancy. In his role, Martin oversees a multidisciplinary team dedicated to elucidating the intricate interactions within the tumor microenvironment (TME) and macroenvironment, aiming to identify novel therapeutic targets and improve treatment strategies for late-stage cancers. His expertise spans cancer biology, biochemistry, and molecular biology, with a particular emphasis on tumor-stroma interactions, immune modulation, and cellular signaling pathways.

One of Martin’s key projects involves dissecting the cellular and molecular crosstalk within the TME that promotes tumor growth, metastasis, and resistance to therapy. By leveraging advanced in vitro and in vivo models, he employs techniques such as molecular cloning, RNA isolation, and assay development to characterize tumor-associated cell populations and their functional roles. His work integrates project management skills with a deep understanding of assay development and experimental design, ensuring robust and reproducible results that can translate into clinical insights.

As a research project leader in late-stage cancer research, Martin is also committed to mentoring junior scientists and fostering collaborative efforts across disciplines. His strong presentation and paper drafting skills support the dissemination of impactful scientific findings through peer-reviewed publications and conference presentations. With a focus on translational research, Martin’s work at Boehringer Ingelheim aims to bridge fundamental science with therapeutic innovation, ultimately contributing to the development of more effective treatments for patients battling advanced cancers.

Martin Augsten Work